KURA CIK: 1422143

Kura Oncology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−105
FY22:
−110
FY23:
−125
FY24:
134
FY25:
−64.1
Change from FY21 to FY25
millions USD
FY21:
−127
FY22:
32.6
FY23:
15.6
FY24:
−102
FY25:
−13.1
Change from FY21 to FY25
millions USD
FY21:
−3.44
FY22:
38.6
FY23:
94.8
FY24:
154
FY25:
1.79
millions USD
FY21:
−235
FY22:
−38.9
FY23:
−14.5
FY24:
187
FY25:
−75.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−106
FY22:
−111
FY23:
−125
FY24:
134
FY25:
−70.7

All amounts in millions USD Data source:SEC EDGAR